Helius Medical Tech Partners with Lovell® Government Services to Expand MS Therapy

 Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced it has partnered with Lovell Government Services (“Lovell”), an SBA-certified Service Disabled Veteran Owned Small Business (“SDVOSB”), to make the Company’s Portable Neuromodulation Stimulator (“PoNS®”) device available to federal healthcare systems. PoNS is indicated in the U.S. for use as a short-term treatment of gait deficit in adults with mild-to-moderate symptoms from MS when used in conjunction with physical therapy.

https://www.globenewswire.com/news-release/2024/04/03/2856799/0/en/Helius-Medical-Technologies-Inc-Announces-Partnership-with-Lovell-Government-Services-to-Expand-Reach-of-PoNS-Therapy.html